114 related articles for article (PubMed ID: 12750039)
1. A new screening model for safety evaluation of superantigen-antibody recombinant fusion proteins (mAb Fab-SEA/E) using telemetric monitoring in conscious rabbits.
Ilbäck NG; Persson R; Gunnarsson K; Stålhandske T
J Pharmacol Toxicol Methods; 2002; 48(1):31-9. PubMed ID: 12750039
[TBL] [Abstract][Full Text] [Related]
2. Effects of a superantigen-antibody recombinant fusion protein (r-C242 Fab-SEA) on toxicological responses in the anaesthetised rabbit.
Ilbäck NG; Gunnarsson K; Persson R; Lindh U; Stålhandske T
Toxicology; 2003 Mar; 185(1-2):161-74. PubMed ID: 12505454
[TBL] [Abstract][Full Text] [Related]
3. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cardiovascular effects of caffeine using telemetric monitoring in the conscious rat.
Ilbäck NG; Siller M; Stålhandske T
Food Chem Toxicol; 2007 May; 45(5):834-42. PubMed ID: 17175084
[TBL] [Abstract][Full Text] [Related]
5. Effects of buprenorphine on body temperature, locomotor activity and cardiovascular function when assessed by telemetric monitoring in rats.
Ilbäck NG; Siller M; Stålhandske T
Lab Anim; 2008 Apr; 42(2):149-60. PubMed ID: 18435873
[TBL] [Abstract][Full Text] [Related]
6. A cardiovascular monitoring system in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 1: Non-pharmacological validation.
Authier S; Tanguay JF; Gauvin D; Di Fruscia R; Fournier S; Chaurand F; Troncy E
J Pharmacol Toxicol Methods; 2007; 56(2):115-21. PubMed ID: 17587601
[TBL] [Abstract][Full Text] [Related]
7. Genetically engineered superantigens as tolerable antitumor agents.
Hansson J; Ohlsson L; Persson R; Andersson G; Ilbäck NG; Litton MJ; Kalland T; Dohlsten M
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2489-94. PubMed ID: 9122222
[TBL] [Abstract][Full Text] [Related]
8. Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants.
Chui RW; Fosdick A; Conner R; Jiang J; Bruenner BA; Vargas HM
J Pharmacol Toxicol Methods; 2009; 60(1):58-68. PubMed ID: 19426820
[TBL] [Abstract][Full Text] [Related]
9. A cardiovascular monitoring system used in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 2: Pharmacological validation.
Authier S; Tanguay JF; Gauvin D; Fruscia RD; Troncy E
J Pharmacol Toxicol Methods; 2007; 56(2):122-30. PubMed ID: 17587605
[TBL] [Abstract][Full Text] [Related]
10. Perforin and IFN-gamma are involved in the antitumor effects of antibody-targeted superantigens.
Rosendahl A; Kristensson K; Hansson J; Riesbeck K; Kalland T; Dohlsten M
J Immunol; 1998 Jun; 160(11):5309-13. PubMed ID: 9605129
[TBL] [Abstract][Full Text] [Related]
11. Effects of rhIGF-I and insulin-induced hypoglycaemia on cardiovascular parameters recorded with telemetry in the conscious dog.
Ilbäck NG; Gunnarsson K; Stålhandske T
Pharmacol Toxicol; 2002 Feb; 90(2):73-81. PubMed ID: 12071429
[TBL] [Abstract][Full Text] [Related]
12. QA interval as an indirect measure of cardiac contractility in the conscious telemeterised rat: model optimisation and evaluation.
Adeyemi O; Roberts S; Harris J; West H; Shome S; Dewhurst M
J Pharmacol Toxicol Methods; 2009; 60(2):159-66. PubMed ID: 19616109
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer.
Wang Q; Yu H; Zhang L; Ju D; Pan J; Xia D; Yao H; Zhang W; Wang J; Cao X
J Mol Med (Berl); 2002 Sep; 80(9):585-94. PubMed ID: 12226740
[TBL] [Abstract][Full Text] [Related]
14. Timecourse of recovery after surgical intraperitoneal implantation of radiotelemetry transmitters in rats.
Greene AN; Clapp SL; Alper RH
J Pharmacol Toxicol Methods; 2007; 56(2):218-22. PubMed ID: 17596971
[TBL] [Abstract][Full Text] [Related]
15. Superantigen-targeted therapy: phase I escalating repeat dose trial of the fusion protein PNU-214565 in patients with advanced gastrointestinal malignancies.
Alpaugh RK; Schultz J; McAleer C; Giantonio BJ; Persson R; Burnite M; Nielsen SE; Vitek L; Persson B; Weiner LM
Clin Cancer Res; 1998 Aug; 4(8):1903-14. PubMed ID: 9717818
[TBL] [Abstract][Full Text] [Related]
16. An integrated cardiovascular and neurobehavioural functional assessment in the conscious telemetered cynomolgus monkey.
Moscardo E; McPhie G; Fasdelli N; Giarola A; Tontodonati M; Dorigatti R; Meecham K
J Pharmacol Toxicol Methods; 2010; 62(2):95-106. PubMed ID: 20601019
[TBL] [Abstract][Full Text] [Related]
17. Validation of the normal, freely moving Göttingen minipig for pharmacological safety testing.
Markert M; Stubhan M; Mayer K; Trautmann T; Klumpp A; Schuler-Metz A; Schumacher K; Guth B
J Pharmacol Toxicol Methods; 2009; 60(1):79-87. PubMed ID: 19427912
[TBL] [Abstract][Full Text] [Related]
18. The value added by measuring myocardial contractility 'in vivo' in safety pharmacological profiling of drug candidates.
Markert M; Klumpp A; Trautmann T; Mayer K; Stubhan M; Guth B
J Pharmacol Toxicol Methods; 2007; 56(2):203-11. PubMed ID: 17583538
[TBL] [Abstract][Full Text] [Related]
19. Comparison of non-invasive and implanted telemetric measurement of blood pressure and electrocardiogram in conscious beagle dogs.
Ward G; Milliken P; Patel B; McMahon N
J Pharmacol Toxicol Methods; 2012 Sep; 66(2):106-13. PubMed ID: 22525003
[TBL] [Abstract][Full Text] [Related]
20. A new telemetry-based system for assessing cardiovascular function in group-housed large animals. Taking the 3Rs to a new level with the evaluation of remote measurement via cloud data transmission.
Markert M; Trautmann T; Krause F; Cioaga M; Mouriot S; Wetzel M; Guth BD
J Pharmacol Toxicol Methods; 2018; 93():90-97. PubMed ID: 29597013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
